RPAM
Rhenman & Partners Asset Management’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-65,000
| Closed | -$6.41M | – | 95 |
|
|
2021
Q1 | $6.41M | Buy |
65,000
+2,500
| +4% | +$247K | 0.45% | 64 |
|
|
2020
Q4 | $6.78M | Hold |
62,500
| – | – | 0.55% | 57 |
|
|
2020
Q3 | $6.44M | Buy |
62,500
+12,500
| +25% | +$1.29M | 0.57% | 56 |
|
|
2020
Q2 | $10.4M | Sell |
50,000
-5,000
| -9% | -$1.04M | 1.13% | 37 |
|
|
2020
Q1 | $5.37M | Sell |
55,000
-10,000
| -15% | -$977K | 0.75% | 52 |
|
|
2019
Q4 | $7.49M | Buy |
65,000
+53,033
| +443% | +$6.11M | 0.82% | 52 |
|
|
2019
Q3 | $652K | Hold |
11,967
| – | – | 0.08% | 80 |
|
|
2019
Q2 | $1.42M | Hold |
11,967
| – | – | 0.16% | 73 |
|
|
2019
Q1 | $627K | Hold |
11,967
| – | – | 0.07% | 76 |
|
|
2018
Q4 | $377K | Sell |
11,967
-3,430
| -22% | -$108K | 0.04% | 78 |
|
|
2018
Q3 | $931K | Hold |
15,397
| – | – | 0.09% | 71 |
|
|
2018
Q2 | $816K | Buy |
15,397
+2,696
| +21% | +$143K | 0.08% | 73 |
|
|
2018
Q1 | $737K | Hold |
12,701
| – | – | 0.09% | 75 |
|
|
2017
Q4 | $445K | Sell |
12,701
-2,700
| -18% | -$94.6K | 0.06% | 88 |
|
|
2017
Q3 | $562K | Hold |
15,401
| – | – | 0.07% | 82 |
|
|
2017
Q2 | $385K | Hold |
15,401
| – | – | 0.06% | 94 |
|
|
2017
Q1 | $416K | Hold |
15,401
| – | – | 0.07% | 88 |
|
|
2016
Q4 | $447K | Hold |
15,401
| – | – | 0.09% | 88 |
|
|
2016
Q3 | $633K | Hold |
15,401
| – | – | 0.1% | 90 |
|
|
2016
Q2 | $487K | Hold |
15,401
| – | – | 0.09% | 92 |
|
|
2016
Q1 | $796K | Hold |
15,401
| – | – | 0.16% | 88 |
|
|
2015
Q4 | $1.47M | Hold |
15,401
| – | – | 0.22% | 91 |
|
|
2015
Q3 | $1.27M | Hold |
15,401
| – | – | 0.2% | 89 |
|
|
2015
Q2 | $2.5M | Buy |
15,401
+11,101
| +258% | +$1.8M | 0.3% | 87 |
|
|
2015
Q1 | $1.74M | Buy |
+4,300
| New | +$1.74M | 0.29% | 83 |
|